Organon & Co reported $1 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.94 0.87 Oct/30 2025
FY2025Q2 Jun/2025 1.00 0.94 1.12 Aug/05 2025
FY2025Q1 Mar/2025 1.02 0.96 1.22 May/01 2025
FY2024Q4 Dec/2024 0.90 0.94 0.88 Feb/13 2025
FY2024Q3 Sep/2024 0.87 0.87 Oct/31 2024
FY2024Q2 Jun/2024 1.12 1.31 Aug/06 2024
FY2024Q1 Mar/2024 1.22 1.08 May/02 2024
FY2024Q3 Dec/2023 0.88 0.81 Feb/15 2024


Eps Change Date
Adcock Ingram Holdings ZAR 2.59 0.17 Dec/2024
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Celltrion KRW 810.39 301.74 Jun/2025
Cspc Pharmaceutical CNY 0.13 0.08 Mar/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Glaxosmithkline USD 0.35 0.24 Jun/2025
Kangmei Pharma CNY 0 0 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Laboratorios Farma 0.42 1.39 Jun/2025
Malin Corporation 0 0 Dec/2024
Medical Developments International AUD 0 0.34 Dec/2024
Merck USD 2.13 0.09 Jun/2025
Neuren Pharmaceuticals AUD 1.02 0.96 Dec/2024
Novartis USD 2.06 0.08 Jun/2025
Organigram Holdings CAD -0.05 0.16 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Pharma Mar EUR 1.32 1.55 Jun/2025
Qiagen NV USD 0.6 0.12 Jun/2025
Sartorius EUR 0.47 0.75 Jun/2025
Sino Biopharmaceutical CNY 0.19 0.16 Jun/2025
Tilray USD -1.78 0.54 Jun/2025